Abstract
Lymphoblastic lymphomas (LBL), like acute lymphoblastic leukemia (ALL), comprise of high-grade neoplasms arising from precursor lymphocytes of B- or T-cell lineage. In the great majority, they are of T-cell lineage (more than 75 %) and localize to the mediastinum (more than 80 %), whereas the less frequent B-cell lineage lymphomas have various primary sites. Mediastinal, bone marrow, and CNS involvements are more common in T-LBL, whereas skin, lymph node, and bone involvements are observed most frequently in B-LBL [1]. The incidence of LBL remains relatively constant across ages for both males and females.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jaffe ES, Harris NL, Stein H et al (2008) Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Int Agency Res Cancer, Lyon, pp 157–166
Kostakoglu L, Cheson BD (2013) State-of-the-art research on “lymphomas: role of molecular imaging for staging, prognostic evaluation, and treatment response”. Front Oncol 3:Article 212
Montravers F, McNamara D, Landman-Parker J et al (2002) [(18)F]-FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 29:1155–1165
Rosolen A, Gross T (2012). Chapter 17. Malignant non-Hodgkin lymphomas in children. In: Stevens M, Caron H, Biondi A (eds). Cancer in Children. Clinical Management, 6th ed. New York: Oxford University Press, pp 203–219
Hoelzer D, Gokbuget N, Digel W et al (2002) Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocol for acute lymphoblastic leukemia. Blood 99:4379–4385
Reiter A, Schrappe M, Ludwig WD et al (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95:416–421
Atlas M (2005) Non-Hodgkin lymphoma. In: Lanzkowsky P (ed) Manual of pediatric hematology and oncology. Elsevier Academic Press, London, pp 500–502
Maitra A, McKenna RW, Weinberg AG et al (2001) Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 115:868
Neth O, Seidemann K, Jansen P et al (2000) Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Med Pediatr Oncol 35:20–27
Weiler-Sagie M, Bushelev O, Epelbaum R et al (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51(1):25–30
Cheng G, Servaes S, Zhuang H (2013) Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leuk Lymphoma 54(4):737–742
Kluge R, Kurch L, Montravers F, Mauz-Körholz C (2013) FDG PET/CT in children and adolescents with lymphoma. Pediatr Radiol 43(4):406–417
Cistaro A, Saglio F, Asaftei S et al (2011) The role of 18F-FDG PET/CT in pediatric lymph node acute lymphoblastic leukemia involvement. Radiol Case Rep 6(4):503
Cairo MS (2010) Non Hodgkin’s lymphoma and lymphoproliferative disorders in children. In: Carrol WL, Finlay J (eds) Cancer in children and adolescents. Jones and Bartlett Publishers, Sudbury
EI-Mallawany NK et al (2012) Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J 2(4):e65. doi:10.1038/bcj.2012.8, Epub 2012 Apr 13
Bhojwani D et al (2015) The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 168(6):845–853
Sandlund JT et al (2015) International pediatric non-Hodgkin lymphoma response criteria. J Clin Oncol. doi:10.1200/JCO.2014.59.0745
Acknowledgments
The authors thank Sophia Polychronopoulou and Vassilios Papadakis, Department of Pediatric Hematology-Oncology of “Aghia Sofia” Children’s Hospital, Athens, Greece, and Kalliopi Stefanaki, Department of Pathology of “Aghia Sofia” Children’s Hospital, Athens, Greece, for their contribution by sharing the clinical and imaging data of their patient.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pourtsidis, A.G., Dana, H., Nikaki, A.V., Kritikos, N.V. (2016). Lymphoblastic Lymphoma in Children and Adolescents: Introduction. In: Andreou, J., Kosmidis, P., Gouliamos, A. (eds) PET/CT in Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-27380-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-27380-8_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27378-5
Online ISBN: 978-3-319-27380-8
eBook Packages: MedicineMedicine (R0)